U.S. market Closed. Opens in 6 hours

TYRA | Tyra Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue353.00K296.00K140.00K47.00K8.00K
Gross Profit-353.00K-296.00K-140.00K-47.00K-8.00K
Operating Expenses79.94M58.93M26.29M9.30M3.12M
Selling, General & Admin17.43M15.92M5.65M2.09M1.33M
Research & Development62.52M43.01M20.64M7.20M1.79M
Other Operating ExpensesN/A-50.00K-19.00K-23.00K-8.00K
Operating Income-79.94M-58.93M-26.29M-9.30M-3.12M
Other Expenses / Income10.81M3.60M-6.00K-39.00K-943.00K
Before Tax Income-69.13M-55.33M-26.29M-9.34M-4.07M
Income Tax ExpensesN/A-3.60M-153.00K-22.00K-7.00K
Net Income-69.13M-51.72M-26.14M-9.31M-4.06M
Interest ExpensesN/A-296.00KN/A1.00K1.00K
Basic Shares Outstanding42.70M41.88M41.44M42.54M42.54M
Diluted Shares Outstanding42.70M41.88M41.44M42.54M42.54M
EBITDA-79.59M-58.93M-26.29M-9.27M-3.12M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-69.13M-55.62M-26.29M-9.34M-4.06M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙